Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Overview

This article describes a diagnostic assay that assesses immune responses in transplant recipients, potentially aiding in the decision to withdraw immunosuppression without increasing graft rejection risk.

Key Study Components

Area of Science

• Immunology
• Transplantation
• Diagnostic Assays

Background

• Delayed Type Hypersensitivity principles are utilized.
• Assessment of donor-specific immune responses is crucial for transplant management.
• Accurate monitoring can improve patient outcomes.
• Understanding both effector and regulatory responses is essential.

Purpose of Study

• To develop a reliable assay for monitoring immune responses post-transplant.
• To evaluate the safety of withdrawing immunosuppression.
• To enhance the understanding of recipient immune dynamics.

Methods Used

• Isolation of peripheral blood mononuclear cells (PBMC) from subjects.
• Mixing PBMC with PBS and test antigens.
• Injection of mixtures into skid mice for response measurement.
• Monitoring footpad reactions at specified intervals.

Main Results

• The assay accurately measures both pro and anti-inflammatory responses.
• Results indicate potential for safe immunosuppression withdrawal.
• Demonstrated effectiveness in assessing donor-specific responses.
• Footpad measurements provide quantifiable data on immune activity.

Conclusions

• The trans vivo DTH assay is a promising tool for transplant management.
• It can help tailor immunosuppression strategies for individual patients.
• Further research is needed to validate findings across larger cohorts.

Frequently Asked Questions